In Indiana, we see the benefits of having a strong healthcare and life sciences sector every day. It accounts for one in every ten jobs in the state, provides an annual economic impact of over $80 billion, and is present in the substantial assets spanning the corporate, university and philanthropic sectors. And, in 2020 it was the epicenter of Indiana’s response to the COVID-19 pandemic.
The infrastructure required to activate this response was the result of decades of investment in money, talent, and time, by all members of the healthcare and life sciences sector. From investments in facilities, equipment, research, talent, and connections through BioCrossroads, Indiana’s healthcare and life sciences sector has a substantial collective impact on the vitality of our region. In a new report, TEConomy Partners, LLC. examined the influence of these investments on Central Indiana and how they help provide benefits to Indiana’s other sectors including manufacturing, technology, and retail.
In the Sept. 10 Frameworx, as report author Simon Tripp, Principal and Senior Director at TEConomy Partners, discusses their findings, sharing not only the economic measures of wages and jobs, but also describes the ecosystem that goes beyond traditional research and development underscoring importance of continued investment in the sector. Also presenting and participating in a panel discussion:
- Nora Doherty, Vice President, Finance and Managing Director of Seed Funds, BioCrossroads
- Anne Hathaway, Executive Director, Indiana Medical Device Manufacturers Council
- Dr. Ryan Nagy, President, IU Health Adult Academic Health Center
- Dave Roberts, Chief Innovation Officer, Indiana Economic Development Corporation